FDA panel recommends authorization of COVID vaccines for children under 5

The decision to recommend their authorization was unanimous, with none of the twenty-one members dissenting.

ADVERTISEMENT
Image
Jarryd Jaeger Vancouver, BC
ADVERTISEMENT

A panel of advisors at the Food and Drug Administration has recommended the authorization of COVID-19 vaccines for children under 5 years of age.

The vaccines still face numerous hurdles before they will be given the green light to be used, however the process is expected to happen quickly after this panel's authorization.

As NBC News reports, the Vaccine and Related Biological Products Advisory Committee met on Wednesday to discuss and vote for the use of Pfizer and Moderna vaccines for children ages 6 months to 4 years and 6 months to 5 years, respectively

The decision to recommend their authorization was unanimous, with none of the twenty-one members dissenting.

In the coming days, the FDA is expected to grant an emergency use authorization for the vaccines, while an advisory panel for the Centers for Disease Control will decide whether to offer their endorsement this weekend. Once those steps are completed, the only thing standing between the vaccines and children across America is the signature of CDC Director Dr. Rochelle Walensky.

The push to vaccinate children has been the cause of much debate, with some saying it is unnecessary given COVID-19's effect on younger people, and others arguing that precautionary protection is worth it.

Historically, children have generally been the age demographic to be least likely to contract the virus, and least likely to die if they do contact it, according to CDC data.

"I know that the death rate from COVID among young children may not be extremely high," said committee member Dr. Jay Portnoy, "but it's absolutely terrifying to parents to have their child be sick and have to go to the hospital or even go to the emergency room or their primary care doctor because they’re sick and having trouble breathing."

According to data obtained by NBC News, Moderna vaccines are given via two child-size doses four weeks apart, and have a 40 to 50 percent efficacy rate against mild omicron infections. The company said they expect boosters will be necessary "at some point in time."

In clinical trials, Pfizer's three-dose regimen was 80 percent effective.

ADVERTISEMENT
ADVERTISEMENT

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2024 The Post Millennial, Privacy Policy | Do Not Sell My Personal Information